VS
Vadepalli Shiva Praveen
About Vadepalli Shiva Praveen
Data last updated:
Vadepalli Shiva Praveen is a Director at Sunventies Pharmaceuticals Private Limited (since 2023) and Director at Skymac Pharmaceuticals (Opc) Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Sunventies Pharmaceuticals Private Limited at ₹9.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunventies Pharmaceuticals Private Limited U46497TS2023PTC173129 | Director | 17 May 2023 | 2023 | ₹9.9 Lakh (FY 2025) | Active |
| Skymac Pharmaceuticals (Opc) Private Limited U46497TS2023OPC180045 | Director | 15 Dec 2023 | 2023 | Active |
Board colleagues of Vadepalli Shiva Praveen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srinivas Vadepalli | 10770875 | Sunventies Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vadepalli Shiva Praveen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vadepalli Shiva Praveen
Vadepalli Shiva Praveen currently holds 2 directorships: Sunventies Pharmaceuticals Private Limited (Director, since 17 May 2023, revenue ₹9.9 Lakh (FY 2025)); Skymac Pharmaceuticals (Opc) Private Limited (Director, since 15 Dec 2023).
Vadepalli Shiva Praveen was first appointed on 17 May 2023 as Director at Sunventies Pharmaceuticals Private Limited.
The current boards of Vadepalli Shiva Praveen's companies include Srinivas Vadepalli (Sunventies Pharmaceuticals Private Limited).